PDprotec®
Peritoneal Dialysis (Renal Replacement Therapy)
Phase 2Active
Key Facts
About Zytoprotec
Zytoprotec is a private, pre-revenue biotech start-up developing PDprotec®, a novel peritoneal dialysis fluid designed to be more biocompatible and protective of the peritoneal membrane. The company has completed Phase 1 and 2 trials demonstrating safety and efficacy, and is backed by a world-class Scientific Advisory Board. With significant recent financing, Zytoprotec aims to fund further clinical development to substantiate systemic benefits and position PDprotec® to capture a share of the multi-billion dollar dialysis fluid market.
View full company profile